Cultural
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 14th + KARMAN POPS DOUBLE DIGIT IPO
NEW YORK,Feb. 14,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insight
Fosun International Continues to be Recognized in the S&P Global's Sustainability Yearbook 2025
HONG KONG,Feb. 14,2025-- On 12 February 2025,S&P Global released the Sustainability Yearbook 2025.Fosun International Limited (HKEX Stock Code: 00656,"Fosun International") was successfu
CIMB Singapore Maintains Leading Position On Returns For New Business Accounts Opening
New customers enjoy 3.0%*p.a. on SGD BusinessGo / BusinessGo-i Account and 3.8%* p.a. on USD Interest Plus Current Account / USD BusinessGo-i Account
IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Hong Kong Department of Health
SHANGHAI and NANJING,China and SAN JOSE,Calif.,Feb. 14,2025-- IASO Biotherapeutics ("IASO Bio"),a biopharmaceutical company focused on the discovery,development,manufacturing,and commerciali
Inaugural Longines Hong Kong International Horse Show Unveiled: AsiaWorld-Expo Transforms into a Five-Star Equestrian Paradise, Delivering an Extraordinary Spectacle
HONG KONG,Feb. 14,2025-- For the first time,the prestigious five-star international equestrian event with over 50 years of history in London has chosen Hong Kong as its venue,heralding the fruitful Ye
Thousand-year-old temple fair held in Central China's Henan
XUN COUNTY,China,Feb. 14,2025-- On February 6,2025,the ninth day of the first lunar month,the 17th Central Plains (Hebi) Folk Culture Festival ushered in the Dapishan Temple Fair. The event was a vibr
Snail Games Celebrates Pivotal Milestones and New Content for the ARK Franchise
CULVER CITY,Calif.,Feb. 14,2025-- Snail Games (Nasdaq: SNAL),a premier global developer and publisher of interactive digital entertainment,celebrates new milestones that are reshaping the ARK universe
Antengene Announces XPOVIO® Approved for Public Health Insurance Coverage in Taiwan Market, Benefiting More Patients with R/R MM in the Region
XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).
Hugel achieves record net sales, profit, net income in 2024
- The company reports KRW373.0 billion in net sales,KRW166.3 billion in operating profit,and KRW142.4 billion in net income,reflecting year-over-year increases of 16.7%,41.2%,and 45.8%,respectively
Hyundai Motor Group Celebrates 20 Years of Driving Innovation at the Hyundai California Proving Ground
Milestone reaffirms Hyundai Motor Group\'s commitment to safety,quality,design,and performance More than 5,000 vehicles have been tested and driven more than 20-million miles at the facility since ope